Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Interesting to see Ventripoint mentioned with Holly Scott .
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Comment by jopatcloon May 11, 2024 7:41am
76 Views
Post# 36035043

RE:Interesting to see Ventripoint mentioned with Holly Scott .

RE:Interesting to see Ventripoint mentioned with Holly Scott .Interesting and good comment Synergy GA might sneak to this one on his
own dime as I think he would have lots of
friends in Boston from past company's he pioneered:
nice see Ventripoint and Duke University ( Ventripoint Diagnostics Ltd. continues positive momentum in their #AI #heart Scan Technology with purchase from Duke University Health Hugh MacNaught ) !on post Holly Scott Happy Sunday! Busy week in #MedTech, Let's check out the news highlights: 6 days ago

Looking forward to next week's Heart Rhythm Society meeting in Boston! Dominic Lynch and I will be attending and meeting industry friends, old and new. Be sure to say hello if you plan to attend.

HRS2024 heartrhythm electrophysiology EP cardiology heart hearthealth medtech The Mullings Group innovation medicaldevices
Looking forward to next week's Heart Rhythm Society meeting in Boston! Dominic Lynch and I will be attending and meeting industry friends, old and new. Be sure to say hello if you plan to attend.

HRS2024 heartrhythm electrophysiology EP cardiology heart hearthealth medtech The Mullings Group innovation medicaldevices

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities